These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7425591)

  • 21. Antiviral chemotherapy--a frontier for health and learning.
    Jackson GG
    Yale J Biol Med; 1982; 55(3-4):369-74. PubMed ID: 6295012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global resistance trends and the potential impact on empirical therapy.
    Isturiz R
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S201-6. PubMed ID: 19134520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The essential features of microorganisms and the rationale for antimicrobial therapy.
    Douglas CW
    Br Dent J; 1992 May; 172(9):339-43. PubMed ID: 1389584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004].
    Mroczkowski P; Lauf H; Lippert H; König W; Meyer F
    Zentralbl Chir; 2009 Jun; 134(3):226-30. PubMed ID: 19536716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infectious diseases-Part II: New agents, resistances, and treatment strategies].
    Salzberger B; Franzen C; Glück T
    Med Klin (Munich); 2004 May; 99(5):251-60. PubMed ID: 15146288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical infectiology--I. Diagnosis, pathogen spectrum and resistance].
    Schrappe M
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():166-75. PubMed ID: 8657083
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic challenges in the era of antibiotic resistance.
    Lee C
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
    Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE
    Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological factors influencing the emergence of antimicrobial resistance.
    Cohen ML
    Ciba Found Symp; 1997; 207():223-31; discussion 231-7. PubMed ID: 9189644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On new antiviral drugs, new viruses and old known bacteria].
    Flückiger U
    Schweiz Med Wochenschr; 1999 Dec; 129(51-52):2005-9. PubMed ID: 10674309
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention, diagnosis and therapy of infections in patients with malignant diseases].
    Hiddemann W; Maschmeyer G; Runde V; Einsele H
    Internist (Berl); 1996 Dec; 37(12):1212-24. PubMed ID: 9081922
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prospects for bacteriological studies and chemotherapy of bacterial infections].
    Jeljaszewicz J
    Pol Tyg Lek; 1979 Jan; 34(2):41-2. PubMed ID: 424331
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current problems of antibacterial therapy].
    Ludwig E
    Orv Hetil; 1998 Sep; 139(37):2179-84. PubMed ID: 9769686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New trends in antibacterial and antiviral therapy].
    Alekseev GK
    Klin Med (Mosk); 1985 Feb; 63(2):12-7. PubMed ID: 3887019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.